Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta-analysis

Chest

Volumn 151, Issue 3, 2017, Pages 544-554

  Aleva, Floor E ^a   Voets, Lucas W L M ^a   Simons, Sami O ^a   de Mast, Quirijn ^a   van der Ven, André J A M ^a   Heijdra, Yvonne F ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

COPD; meta analysis; prevalence; pulmonary embolism

Indexed keywords

ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DIABETES MELLITUS; DISEASE EXACERBATION; DISEASE SEVERITY; HEART FAILURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MORTALITY; PHYSICAL EXAMINATION; PREVALENCE; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SMOKING; SYSTEMATIC REVIEW; THORAX PAIN; ACUTE DISEASE; CHEST PAIN; DIAGNOSTIC IMAGING; DISEASE COURSE; LENGTH OF STAY; META ANALYSIS; PULMONARY ARTERY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMBOLISM; STATISTICS AND NUMERICAL DATA;

ACUTE DISEASE; CHEST PAIN; COMPUTED TOMOGRAPHY ANGIOGRAPHY; DISEASE PROGRESSION; HEART FAILURE; HUMANS; LENGTH OF STAY; MORTALITY; PREVALENCE; PULMONARY ARTERY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMBOLISM;

EID: 85014550330     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.07.034     Document Type: Article

References (63)

1. 1 Murray, C.J., Lopez, A.D., Measuring the global burden of disease. N Engl J Med 369:5 (2013), 448–457.
2. 2 Murray, C.J., Lopez, A.D., Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349:9061 (1997), 1269–1276.
3. 3 US Department of Health and Human Services. Chronic Obstructive Pulmonary Disease. Washington DC: USDHHS. 2003. Data fact sheet.
4. 4 Global Initiative for Chronic Obstructive Lung Diseases (GOLD): update 2014. www.goldcopd.org. Accessed March 5, 2016.
5. 5 Ho, T.W., Tsai, Y.J., Ruan, S.Y., et al. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study. PloS One, 9(12), 2014, e114866.
6. 6 Soler-Cataluna, J.J., Martinez-Garcia, M.A., Roman Sanchez, P., Salcedo, E., Navarro, M., Ochando, R., Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60:11 (2005), 925–931.
7. 7 Wedzicha, J.A., Donaldson, G.C., Natural history of successive COPD exacerbations. Thorax 67:11 (2012), 935–936.
8. 8 Connors, A.F. Jr., Dawson, N.V., Thomas, C., et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 154:4 Pt 1 (1996), 959–967.
9. 9 Sidney, S., Sorel, M., Quesenberry, C.P. Jr., DeLuise, C., Lanes, S., Eisner, M.D., COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 128:4 (2005), 2068–2075.
10. 10 Rizkallah, J., Man, S.F., Sin, D.D., Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest 135:3 (2009), 786–793.
11. 11 Tillie-Leblond, I., Marquette, C.H., Perez, T., et al. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med 144:6 (2006), 390–396.
12. 12 Shapira-Rootman, M., Beckerman, M., Soimu, U., Nachtigal, A., Zeina, A.R., The prevalence of pulmonary embolism among patients suffering from acute exacerbations of chronic obstructive pulmonary disease. Emerg Radiol 22:3 (2015), 257–260.
13. 13 Saghazadeh, A., Rezaei, N., Inflammation as a cause of venous thromboembolism. Crit Rev Oncol Hematol 99:1 (2016), 272–285.
14. 14 Lankeit, M., Held, M., Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis?. Eur Respir J 47:2 (2016), 369–373.
15. 15 Polosa, R., Malerba, M., Cacciola, R.R., et al. Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in patients with COPD. Intern Emerg Med 8:7 (2013), 567–574.
16. 16 Curkendall, S.M., DeLuise, C., Jones, J.K., et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in patients with COPD. Ann Epidemiol 16:1 (2006), 63–70.
17. 17 Tichelaar, Y.I., Kluin-Nelemans, H.J., Meijer, K., Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic review. Thromb Haemost 107:5 (2012), 827–837.
18. 18 Schneider, C., Bothner, U., Jick, S.S., Meier, C.R., Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol 25:4 (2010), 253–260.
19. 19 Borvik, T., Braekkan, S.K., Enga, K., et al. COPD and risk of venous thromboembolism and mortality in a general population. Eur Respir J 47:2 (2016), 473–481.
20. 20 Alkim H, Koksal AR, Boga S, Sen I, Alkim C. Etiopathogenesis, prevention, and treatment of thromboembolism in inflammatory bowel disease [published online ahead of print February 18, 2016]. Clin Appl Thomb Hemost. http://dx.doi.org/10.1177/1076029616632906.
21. 21 Esmon, C.T., The interactions between inflammation and coagulation. Br J Haematol 131:4 (2005), 417–430.
22. 22 Wagner, D.D., Burger, P.C., Platelets in inflammation and thrombosis. Aterioscler Thromb Vasc Biol 23:12 (2003), 2131–2137.
23. 23 Mortensen, J., Gutte, H., SPECT/CT and pulmonary embolism. Eur J Nucl Med Mol Imaging 41:suppl 1 (2014), 81–90.
24. 24 Rathbun, S.W., Raskob, G.E., Whitsett, T.L., Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med 132:3 (2000), 227–232.
25. 25 Carrier, M., Righini, M., Wells, P.S., et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost 8:8 (2010), 1716–1722.
26. 26 den Exter, P.L., van Es, J., Klok, F.A., et al. Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism. Blood 122:7 (2013), 1144–1149 quiz 1329.
27. 27 Donato, A.A., Khoche, S., Santora, J., Wagner, B., Clinical outcomes in patients with isolated subsegmental pulmonary emboli diagnosed by multidetector CT pulmonary angiography. Thromb Res 126:4 (2010), e266–e270.
28. 28 Kearon, C., Akl, E.A., Ornelas, J., et al. Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report. Chest 149:2 (2016), 315–352.
29. 29 Peiman, S., Abbasi, M., Allameh, S.F., Asadi Gharabaghi, M., Abtahi, H., Safavi, E., Subsegmental pulmonary embolism: a narrative review. Thromb Res 138:1 (2016), 55–60.
30. 30 Moua, T., Wood, K., COPD and PE: a clinical dilemma. Int J Chron Obstruct Pulmon Dis 3:2 (2008), 277–284.
31. 31 Akpinar, E.E., Hosgun, D., Akpinar, S., Atac, G.K., Doganay, B., Gulhan, M., Incidence of pulmonary embolism during COPD exacerbation. J Bras Pneumol 40:1 (2014), 38–45.
32. 32 Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Group, P., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med, 6(7), 2009, e1000097.
33. 33 Barendregt, J.J., Doi, S.A., Yong Yi, L., Norman, R.E., Vos, T., Meta-analysis of prevalence. J Epidemiol Community Health 67:11 (2013), 974–978.
34. 34 Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327:7414 (2003), 557–560.
35. 35 R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2014. Vienna, Austria. http://www.R-project.org. Accessed May 29, 2016.
36. 36 Viechtbauer, W., Conducting meta-analyses in R with the metafor package. J Stat Software, 36(3), 2010, 48.
37. 37 Akpinar, E.E., Hosgun, D., Doganay, B., Atac, G.K., Gulhan, M., Should the cut-off value of D-dimer be elevated to exclude pulmonary embolism in acute exacerbation of COPD?. J Thorac Dis 5:4 (2013), 430–434.
38. 38 Choi, K.J., Cha, S.I., Shin, K.M., et al. Prevalence and predictors of pulmonary embolism in Korean patients with exacerbation of chronic obstructive pulmonary disease. Respiration 85:3 (2013), 203–209.
39. 39 Gunen, H., Gulbas, G., In, E., Yetkin, O., Hacievliyagil, S.S., Venous thromboemboli and exacerbations of COPD. Eur Respir J 35:6 (2010), 1243–1248.
40. 40 Kamel, M.M., Moussa, H., Ismail, A., Prevalence of venous thrombo-embolism in acute exacerbations of chronic obstructive pulmonary disease. Egyptian J Chest Dis Tuberculosis 62:4 (2013), 557–566.
41. 41 Rutschmann, O.T., Cornuz, J., Poletti, P.A., et al. Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease?. Thorax 62:2 (2007), 121–125.
42. 42 Hartmann, I.J., Hagen, P.J., Melissant, C.F., Postmus, P.E., Prins, M.H., Diagnosing acute pulmonary embolism: effect of chronic obstructive pulmonary disease on the performance of D-dimer testing, ventilation/perfusion scintigraphy, spiral computed tomographic angiography, and conventional angiography. ANTELOPE Study Group. Advances in New Technologies Evaluating the Localization of Pulmonary Embolism. Am J Respir Crit Care Med 162:6 (2000), 2232–2237.
43. 43 Lesser, B.A., Leeper, K.V. Jr., Stein, P.D., et al. The diagnosis of acute pulmonary embolism in patients with chronic obstructive pulmonary disease. Chest 102:1 (1992), 17–22.
44. 44 Gladish, G.W., Choe, D.H., Marom, E.M., Sabloff, B.S., Broemeling, L.D., Munden, R.F., Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history. Radiology 240:1 (2006), 246–255.
45. 45 Ritchie, G., McGurk, S., McCreath, C., Graham, C., Murchison, J.T., Prospective evaluation of unsuspected pulmonary embolism on contrast enhanced multidetector CT (MDCT) scanning. Thorax 62:6 (2007), 536–540.
46. 46 Karadag, F., Karul, A.B., Cildag, O., Yilmaz, M., Ozcan, H., Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung 186:6 (2008), 403–409.
47. 47 Kersul, A.L., Iglesias, A., Rios, A., et al. Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol 47:4 (2011), 176–183.
48. 48 Wei, J., Xiong, X.F., Lin, Y.H., Zheng, B.X., Cheng, D.Y., Association between serum interleukin-6 concentrations and chronic obstructive pulmonary disease: a systematic review and meta-analysis. PeerJ, 3, 2015, e1199.
49. 49 Johannesdottir, S.A., Horvath-Puho, E., Dekkers, O.M., et al. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 173:9 (2013), 743–752.
50. 50 Gurewich, V., Thomas, D., Stein, M., Wessler, S., Bronchoconstriction in the presence of pulmonary embolism. Circulation 27 (1963), 339–345.
51. 51 Robinson, A.E., Puckett, C.L., Green, J.D., Silver, D., In vivo demonstration of small-airway bronchoconstriction following pulmonary embolism. Radiology 109:2 (1973), 283–286.
52. 52 Windebank, W.J., Boyd, G., Moran, F., Pulmonary thromboembolism presenting as asthma. Br Med J 1:5845 (1973), 90–94.
53. 53 Sapey, E., Stockley, R.A., COPD exacerbations. 2: aetiology. Thorax 61:3 (2006), 250–258.
54. 54 White, R.H., The epidemiology of venous thromboembolism. Circulation 107:23 suppl 1 (2003), I4–I8.
55. 55 Stein, P.D., Athanasoulis, C., Alavi, A., et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 85:2 (1992), 462–468.
56. 56 van Es N, van der Hulle T, van Es J, et al. Wells rule and D-dimer testing to rule out pulmonary embolism: a systematic review and individual-patient data meta-analysis [published online ahead of print May 17, 2016]. Ann Intern Med. http://dx.doi.org/10.7326/M16-0031.
57. 57 Klatsky, A.L., Armstrong, M.A., Poggi, J., Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 85:11 (2000), 1334–1337.
58. 58 Leclercq, M.G., Lutisan, J.G., van Marwijk Kooy, M., et al. Ruling out clinically suspected pulmonary embolism by assessment of clinical probability and D-dimer levels: a management study. Thromb Haemost 89:1 (2003), 97–103.
59. 59 Perrier, A., Desmarais, S., Goehring, C., et al. D-dimer testing for suspected pulmonary embolism in outpatients. Am J Respir Crit Care Med 156:2 Pt 1 (1997), 492–496.
60. 60 Deonarine, P., de Wet, C., McGhee, A., Computed tomographic pulmonary angiography and pulmonary embolism: predictive value of a d-dimer assay. BMC Res Notes, 5(1), 2012, 104.
61. 61 Dwan, K., Gamble, C., Williamson, P.R., Kirkham, J.J., Reporting Bias Group. Systematic review of the empirical evidence of study publication bias and outcome reporting bias—an updated review. PloS One, 8(7), 2013, e66844.
62. 62 Kicinski, M., Publication bias in recent meta-analyses. PloS One, 8(11), 2013, e81823.
63. 63 Heit, J.A., Silverstein, M.D., Mohr, D.N., et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 86:1 (2001), 452–463.